This update of the original Cochrane review published in 2013 examines which permanent and temporary changes to the water environments of immature mosquitoes work better to reduce malaria in people?
Research in 1900 suggested house modifications may reduce malaria transmission. A previous version of this review concluded that house screening may be effective in reducing malaria. This update includes data from five new studies.
The WHO recommends parasitological testing of all suspected malaria cases using malaria rapid diagnostic tests (mRDTs) or microscopy prior to treatment. This update of a 2013 Cochrane Review examines whether adding mRDTs to community-based malaria programmes improves treatment of people with malaria or fever.
Authors of this updated Cochrane review concluded that pyronaridine-artesunate is as effective as other antimalarials and is safe in treating uncomplicated cases of an important type of malaria (Plasmodium falciparum).
The objective of this review update is to summarize the effect on malaria of additionally implementing IRS, using non‐pyrethroid‐like or pyrethroid‐like insecticides, in communities currently using ITNs.
Treating everyone for malaria: does it eliminate the disease? Some policy experts recommend giving antimalarial drugs to everyone living in a malarious area at the same time to accelerate elimination of the disease, but this is controversial.
This Cochrane review explored whether community administration of ivermectin influences malaria transmission.
Pyrethroid + PBO bed nets reduce malaria infection in areas of high pyrethroid resistance
What are the benefits and risks of atovaquone‐proguanil for treating uncomplicated malaria caused by the Plasmodium falciparum parasite?
Treating uncomplicated malaria in children: do child‐friendly formulations of medicines work better than usual tablet formulations?
Which types and brands of RDTs are the most accurate for diagnosing P vivax malaria?
This review evaluates the effects of house modifications on malaria disease and transmission.
The aim of this review was to see if tafenoquine could prevent relapses of vivax infections and if this effect is equivalent to that of standard‐dose primaquine.
Primaquine to cure people with Plasmodium vivax malaria: comparing dosing schedules
Intermittent preventive treatment could help prevent malaria in infants (IPTi) living in areas of moderate to high malaria transmission in sub‐Saharan Africa.
Evaluating whether larviciding with chemical or microbial insecticides prevents malaria transmission.
Primaquine to cure people with Plasmodium vivax malaria: comparing dosing schedules.
Artemether injection for treating people with severe malaria
The aim of this review was to summarize the impact of pyrethroid‐like or non‐pyrethroid‐like IRS on malaria, when implemented in communities that are using ITNs.
The aim of this Cochrane Review was to find out if the antimalarial drug pyronaridine‐artesunate is effective and safe to treat uncomplicated cases of an important type of malaria (P falciparum). We collected and analysed all relevant studies to answer this question and found 10 studies.
The aim of this Cochrane Review was to find out if pyrethroid‐PBO nets add additional protection against malaria when compared to standard pyrethroid‐only nets.
The aim of this review update was to evaluate the available evidence and find out whether ITNs continue to be effective at controlling the disease. Cochrane researchers collected and analysed relevant studies and assessed the overall certainty of the evidence.
In order to guide decision‐making for malaria control programmes, the aim of this Cochrane Review was to summarize the actions taken and reported findings of trials evaluating the impact of space spraying on malaria transmission.